Perez-Chada, Lourdes M. http://orcid.org/0000-0001-7724-7309
Salame, Nicole F.
Ford, Adam R.
Duffin, Kristina Callis
Garg, Amit
Gottlieb, Alice B.
Latella, John
Merola, Joseph F.
Armstrong, April W.
Article History
First Online: 16 January 2020
Compliance with Ethical Standards
:
: International Dermatology Outcome Measures (IDEOM) funded the conduct of this study.
: Dr. Garg is a consultant/advisor for Abbvie, Pfizer, UCB, and Asana Biosciences and received a grant from UCB. Dr. Gottlieb is an advisor/consultant for Janssen Inc., Celgene, Beiersdorf, BMS, Abbvie, UCB, Novartis, Incyte Corporation, Lilly, Reddy Labs, Valeant, Dermira, Allergan, Sun Pharmaceutical Industries, XBiotech, Leo, Avotres Therapeutics, and Boeringer Ingelheim. She received research/educational grants from Janssen, Incyte Corporation, XBiotech, Novartis, Boeringer Ingelheim, and UCB. In addition, she participated in the development of the National Psoriasis Foundation Psoriasis Score, an instrument discussed in the present study. John Latella is an advisor for Boehringer Ingelheim and Glaxo Smith Kline. Dr. Duffin serves as an advisory board/consultant/investigator for Amgen, Abbvie, Celgene, Novartis, Lilly, Pfizer, Stifle, Janssen, Ortho Dermatologic, and Boehringer Ingelheim. In addition, she has participated in validation studies of the IGA×BSA, an instrument discussed in the present study. Dr. Merola has served as a consultant/investigator/advisory board for Merck, AbbVie Eli Lilly, Incyte, Janssen, UCB, Almirall, Pfizer, Sun Pharma, Novartis, and Burrage Capital Mgmt. In addition, he received grants from Aclaris, Novartis, Leo, Celgene, and Dermavent. Dr. Armstrong serves as a consultant/advisor/investigator for Leo Pharma, Novartis, Delmira, UCB, Abbvie, Janssen, Eli Lilly, Regeneron and Sanofi, Science 37, Modernizing Medicine, Merck, Parexel, Celgene, Ortho Dermatologics, and Pfizer. Drs. Perez-Chada, Salame, and Ford have no conflicts of interest that are directly relevant to the content of this article.